Akebia Therapeutics | AKBA - Market Capitalization


Akebia Therapeutics reported $155.4M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 22.44B 10.57B Oct/2026
Amgen USD 195.44B 5.55B Jun/2026
Ardelyx USD 1.48B 63M Mar/2026
Astellas Pharma JPY 3.94T 622.52B Jun/2026
AstraZeneca USD 215.06B 74.93B Oct/2026
Bayer EUR 47.56B 8.87B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Celltrion KRW 42.67T 40.86T Oct/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Exelixis USD 18.9B 4.43B Oct/2026
Fresenius Medical Care EUR 10.55B 766.96M Jun/2026
GlaxoSmithKline GBP 74.9B 785.69M Oct/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 607B 46.61B Oct/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pharma Mar EUR 1.31B 263.2M Jun/2026
Prothena USD 516M 2M Mar/2026
PTC Therapeutics USD 4.94B 1.86B Oct/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
Regeneron Pharmaceuticals USD 100.79B 35.42B Oct/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 99.83B 8.68B Oct/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Sartorius EUR 9.66B 7.77B Oct/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 65.93B 25.23B Jun/2026